Trial Profile

A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zenuzolac (Primary)
Indications Rheumatoid arthritis
Focus Adverse reactions
Sponsors VGX Pharmaceuticals

Most Recent Events

01 Mar 2016 Results from this and the other phase I study, published in the Clinical Pharmacology in Drug Development.
08 Apr 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
27 Mar 2009 Status changed from active, no longer recruiting to completed, as reported in a medeia release from VGX Pharmaceuticals.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com